BGLC - BioNexus Gene Lab Corp
2.67
0.010 0.375%
Share volume: 26,467
Last Updated: 05-07-2025
Healthcare/Services – Health:
-0.02%
PREVIOUS CLOSE
CHG
CHG%
$2.66
0.01
0.00%
View ratios
Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
Report Date | 05-15-2024 | 08-16-2023 | 03-26-2024 | 11-15-2024 | 05-15-2024 | 08-14-2024 | 11-15-2024 | |
Total revenue | 2.377 M | 2.567 M | 2.554 M | 2.273 M | 2.382 M | 1.975 M | 2.630 M | |
Cost of revenue | 2.008 M | 2.227 M | 2.199 M | 2.007 M | 2.017 M | 1.686 M | 2.304 M | |
Gross profit | 368.897 K | 339.714 K | 354.332 K | 266.555 K | 365.031 K | 288.720 K | 326.536 K | |
-7.91% | 4.30% | -24.77% | 36.94% | -20.91% | 13.10% | |||
Operating expenses | 536.872 K | 807.077 K | 3.082 M | -16.955 K | 645.906 K | 759.657 K | 2.130 M | |
Selling general and admin | 536.872 K | 807.077 K | 3.082 M | -16.955 K | 645.906 K | 759.657 K | 2.130 M | |
Research and development | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Total expenses | 536.872 K | 611.913 K | 3.082 M | -307.827 K | 645.906 K | 29.552 K | 2.130 M | |
13.98% | 403.69% | -109.99% | 309.83% | -95.42% | 7,106.57% | |||
Operating income | -50.631 K | -272.199 K | -2.529 M | 257.754 K | -79.028 K | 259.168 K | -1.338 M | |
Ebit | 48.278 K | -275.241 K | -2.329 M | -47.067 K | 98.090 K | 254.688 K | -872.095 K | |
Pretax income | -53.076 K | -275.241 K | -2.533 M | 253.571 K | -83.689 K | 254.688 K | -1.344 M | |
418.58% | 820.20% | -110.01% | -133.00% | -404.33% | -627.63% | |||
Income tax | 0.000 | 15.990 K | 76.418 K | 0.000 | 0.000 | -55.584 K | 1.555 K | |
Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Net income | -69.066 K | -259.251 K | -2.609 M | 308.463 K | -103.757 K | 199.104 K | -1.345 M | |
-275.37% | -906.43% | 111.82% | -133.64% | 291.89% | -775.71% |